Exposure to hepatitis B and C and to HTLV‐1 and 2 among Israeli drug abusers in Jerusalem

Addiction

Volumn 89, Issue 7, 1994, Pages 869-874

  MAAYAN, S ^a   SHUFMAN, E N ^b   ENGELHARD, D ^a   SHOUVAL, D ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Jerusalem Institute for the Treatment of Substance Abuse   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY;

ARTICLE; DRUG ABUSE; ETHNIC GROUP; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INCIDENCE; ISRAEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; REHABILITATION CENTER; T CELL LEUKEMIA; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ADULT; COHORT STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HIV SEROPOSITIVITY; HIV-1; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN; ISRAEL; LIVER FUNCTION TESTS; MALE; RISK FACTORS; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS; SUPPORT, NON-U.S. GOV'T;

EID: 0028214160     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.1994.tb00990.x     Document Type: Article

References (26)

1. Natural history of hepatitis B
2. The serum hepatitis related antigen in illicit drug users
3. Seroepidemiology of hepatitis B virus, infection in the United States: 1976–1980
4. Seroprevalence of HTLV1 and HTLV2 among intravenous drag abusers in clinics for sexually transmitted diseases
5. Antibody to lymphadenopathy associated virus in various groups of illicit drug abusers in N.Y. City
6. Hepatitis C in HIV infected IV drug abusers and homosexual men in suburban N.Y. city
7. Hepatitis C virus antibodies among risk group in Spain
8. Prevalence, incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam
9. Pattern of drug abuse and prevalence of antibodies to HIV in heroin addicts in Jerusalem, 1989
10. Prevalence of sexually transmitted pathogens among women attending a methadone clinic in Israel
11. HIV infection among intravenous drug addicts in Israel: stable low prevalence over 34 months
12. HTLV among Israeli IV drag ahusers
13. The natural history of community acquired Hepatitis C in the United States
14. Type specific antigens for serological discrimination of HTLV1 and HTLV2 infection.
15. Epidemiology of viral hepatitis in Israel in 1978
16. Prevalence of hepatitis B markers (HBsAg and HBsAb) in women screened at time of delivery
17. Strategy for the control of Hepatitis B virus infection in the Middle East and North Africa
18. A seroepidemiologic study of hepatitis B in a rural area in Israel
19. Prevalence of Hepatitis C antibodies in pregnant foreign residents in France
20. Epidemiologic study of anti HCV antibodies in Tunisian blood donors
21. HIV1 infection and IVDA'S: world perspective and epidemiology in Israel
22. Effects of Amsterdan needle and syringe exchange
23. Risk reduction among intravenous drug users in Amsterdam